Richard Gesser

2.9k citations

30 papers · 1.1k indexed · h-index 21

Co-authors: Gail L. Woods Tibor Vályi-Nagy Sophia Koo Nicholas Fraser Kathleen McCarroll Stuart M. Brown J G Spivack Satish L. Deshmane
Topics: Herpesvirus Infections and Treatments (14 papers)Antibiotics Pharmacokinetics and Efficacy (8 papers)Antimicrobial Resistance in Staphylococcus (5 papers)
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Epidemiology
Journals: Clinical Infectious Diseases Journal of Virology Antimicrobial Agents and Chemotherapy
Partner nations: United States Colombia Spain

In The Last Decade

Richard Gesser

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Richard Gesser

Since Specialization

Citations

This map shows the geographic impact of Richard Gesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gesser more than expected).

Fields of papers citing papers by Richard Gesser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gesser. The network helps show where Richard Gesser may publish in the future.

Co-authorship network of co-authors of Richard Gesser

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gesser. A scholar is included among the top collaborators of Richard Gesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gesser. Richard Gesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial 2016 ·Vaccine ·Guy de Bruyn,(unknown),David Workman,Richard Pollak,Victor Elinoff,Neil J. Fraser,Gigi Lefebvre,Mark G. Martens,(unknown),Richard Nathan,Miguel Á. Treviño,Martin van Cleeff,Ginamarie Foglia,Ayca Ozol-Godfrey,Dhaval M. Patel,Patricia J. Freda Pietrobon,Richard Gesser	76
2	Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection 2008 ·International Journal of Antimicrobial Agents ·Adriano Arguedas,(unknown),(unknown),Jeffrey L. Blumer,Ram Yogev,Richard Gesser,Jean Wang,(unknown),(unknown),(unknown)	19
3	Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients 2007 ·The American Journal of Surgery ·Albert E. Yellin,Jeffrey P. Johnson,(unknown),Blaise L. Congeni,Antonio Arrieta,Doreen Fernsler,(unknown),Richard Gesser	19
4	Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam 2004 ·International Journal of Antimicrobial Agents ·Richard Gesser,Kathleen McCarroll,Gail L. Woods	14
5	Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections 2003 ·Journal of Infection ·Richard Gesser,Kathleen McCarroll,Gail L. Woods	29
6	Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data 2003 ·Journal of Antimicrobial Chemotherapy ·Richard Gesser	25
7	A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults 2002 ·Urology ·(unknown),Abel Jasovich,(unknown),Qi Jiang,(unknown),Gail L. Woods,Richard Gesser	47
8	Surgical Infections with Enterococcus : Outcome in Patients Treated with Ertapenem versus Piperacillin-Tazobactam 2002 ·Surgical Infections ·Hedy Teppler,Kathleen McCarroll,Richard Gesser,Gail L. Woods	33
9	Ertapenem versus Piperacillin-Tazobactam for Treatment of Mixed Anaerobic Complicated Intra-Abdominal, Complicated Skin and Skin Structure, and Acute Pelvic Infections 2002 ·Surgical Infections ·José M. Tellado,Gail L. Woods,Richard Gesser,Kathleen McCarroll,Hedy Teppler	17
10	General Microbiology and In Vitro Susceptibility of Anaerobes Isolated from Complicated Skin and Skin‐Structure Infections in Patients Enrolled in a Comparative Trial of Ertapenem Versus Piperacillin‐Tazobactam 2002 ·Clinical Infectious Diseases ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Richard Gesser	27
11	Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections 2002 ·Diagnostic Microbiology and Infectious Disease ·Barbara A. Pelak,Ken Bartizal,Gail L. Woods,Richard Gesser,Mary Motyl	15
12	Ertapenem Once Daily Versus Piperacillin‐Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin‐Structure Infections in Adults: Results of a Prospective, Randomized, Double‐Blind Multicenter Study 2002 ·Clinical Infectious Diseases ·Donald R. Graham,Christopher Lucasti,Osvaldo Malafaia,Ronald Lee Nichols,Paul Holtom,(unknown),(unknown),Gail L. Woods,(unknown),Richard Gesser,(unknown)	117
13	Presence of VZV and HSV-1 DNA in Human Nodose and Celiac Ganglia 2001 ·Virus Genes ·D. H. Gilden,Richard Gesser,John David Smith,Mary Wellish,James J. LaGuardia,Randall J. Cohrs,(unknown)	64
14	Reactivation of herpes simplex virus from latently infected mice after administration of cadmium is mouse-strain-dependent 1996 ·Journal of General Virology ·(unknown),Richard Gesser,(unknown),Nicholas Fraser	12
15	Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 34.5 mutants in a mouse eye model 1995 ·Journal of General Virology ·J G Spivack,Moin U. Fareed,(unknown),(unknown),Stephen J. O’Keefe,Richard Gesser,E. A. McKie,Alasdair Maclean,Nicholas Fraser,Stuart M. Brown	33
16	Restricted Herpes Simplex Virus Type 1 Gene Expression within Sensory Neurons in the Absence of Functional B and T Lymphocytes 1994 ·Virology ·Richard Gesser,Tibor Vályi-Nagy,(unknown)	19
17	The herpes simplex virus type 1 strain 17+ 34.5 deletion mutant 1716 is avirulent in SCID mice 1994 ·Journal of General Virology ·Tibor Vályi-Nagy,Moin U. Fareed,Stephen J. O’Keefe,Richard Gesser,Alasdair Maclean,Stuart M. Brown,J G Spivack,Nicholas Fraser	52
18	Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia) 1994 ·Journal of General Virology ·Richard Gesser,Tibor Vályi-Nagy,(unknown),Nicholas Fraser	28
19	Upper airway obstruction in association with perinatally acquired herpes simplex virus infection 1992 ·The Journal of Pediatrics ·Simon Nadel,Paul A. Offit,Richard L. Hodinka,Richard Gesser,Louis M. Bell	16
20	A review of the molecular mechanism of HSV-1 latency 1991 ·Current Eye Research ·Nicholas Fraser,J G Spivack,Zofia Wróblewska,Timothy M. Block,Satish L. Deshmane,Tibor Vályi-Nagy,(unknown),Richard Gesser	55

About Richard Gesser

Richard Gesser is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Epidemiology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (14 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (118 citations), Molecular Medicine (150 citations) and Epidemiology (662 citations). Richard Gesser has collaborated with scholars based in United States, Colombia and Spain. Frequent co-authors include Gail L. Woods, Tibor Vályi-Nagy, Sophia Koo, Nicholas Fraser, Kathleen McCarroll, Stuart M. Brown, J G Spivack, Satish L. Deshmane, B. Randazzo and Qi Jiang. Their work appears in journals such as Clinical Infectious Diseases, Journal of Virology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact